PetMed Express Stock Price, News & Analysis (NASDAQ:PETS)

$45.09 1.08 (2.45 %)
(As of 12/18/2017 01:32 PM ET)
Previous Close$44.01
Today's Range$43.73 - $45.76
52-Week Range$19.21 - $50.90
Volume966,100 shs
Average Volume648,971 shs
Market Capitalization$929.03 million
P/E Ratio30.26
Dividend Yield1.82%
Beta1.13

About PetMed Express (NASDAQ:PETS)

PetMed Express logoPetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Retail - Drugs without Grocery
Sub-IndustryInternet Retail
SectorRetail/Wholesale
SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Debt-to-Equity RatioN/A
Current Ratio4.91%
Quick Ratio3.72%

Price-To-Earnings

Trailing P/E Ratio30.26
Forward P/E Ratio26.84
P/E Growth2.68

Sales & Book Value

Annual Sales$249.18 million
Price / Sales3.73
Cash Flow$1.23 per share
Price / Cash36.76
Book Value$4.55 per share
Price / Book9.91

Profitability

Trailing EPS$1.49
Net Income$23.81 million
Net Margins11.58%
Return on Equity31.46%
Return on Assets26.35%

Miscellaneous

Employees187
Outstanding Shares20,600,000

PetMed Express (NASDAQ:PETS) Frequently Asked Questions

What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express announced a quarterly dividend on Tuesday, October 24th. Stockholders of record on Monday, November 6th will be given a dividend of $0.20 per share on Friday, November 17th. This represents a $0.80 annualized dividend and a dividend yield of 1.77%. The ex-dividend date is Friday, November 3rd. View PetMed Express' Dividend History.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) announced its quarterly earnings results on Monday, October, 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.30 by $0.13. The business had revenue of $66.70 million for the quarter, compared to the consensus estimate of $63.41 million. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The company's revenue for the quarter was up 9.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.24 earnings per share. View PetMed Express' Earnings History.

When will PetMed Express make its next earnings announcement?

PetMed Express is scheduled to release their next quarterly earnings announcement on Monday, January, 22nd 2018. View Earnings Estimates for PetMed Express.

Where is PetMed Express' stock going? Where will PetMed Express' stock price be in 2017?

5 equities research analysts have issued 12 month price objectives for PetMed Express' shares. Their forecasts range from $19.00 to $54.00. On average, they anticipate PetMed Express' share price to reach $40.00 in the next year. View Analyst Ratings for PetMed Express.

Who are some of PetMed Express' key competitors?

Who are PetMed Express' key executives?

PetMed Express' management team includes the folowing people:

  • Robert C. Schweitzer, Independent Chairman of the Board (Age 71)
  • Menderes Akdag, President, Chief Executive Officer, Director (Age 56)
  • Bruce S. Rosenbloom, Chief Financial Officer, Treasurer (Age 48)
  • Frank J. Formica, Independent Director (Age 73)
  • Gian M. Fulgoni, Independent Director (Age 69)
  • Ronald J. Korn, Independent Director (Age 77)

Who owns PetMed Express stock?

PetMed Express' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (4.16%), Prudential Financial Inc. (4.00%), Bank of New York Mellon Corp (2.07%), Uniplan Investment Counsel Inc. (1.62%), Old Mutual Global Investors UK Ltd. (1.45%) and Ameriprise Financial Inc. (1.39%). Company insiders that own PetMed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for PetMed Express.

Who sold PetMed Express stock? Who is selling PetMed Express stock?

PetMed Express' stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Advisors Asset Management Inc., Rhumbline Advisers, Allianz Asset Management GmbH, First Midwest Bank Trust Division, Isthmus Partners LLC, Virginia Retirement Systems ET AL and Bank of New York Mellon Corp. Company insiders that have sold PetMed Express company stock in the last year include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for PetMed Express.

Who bought PetMed Express stock? Who is buying PetMed Express stock?

PetMed Express' stock was bought by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Old Mutual Global Investors UK Ltd., Uniplan Investment Counsel Inc., Ameriprise Financial Inc., Smith Asset Management Group LP, Robeco Institutional Asset Management B.V., Engineers Gate Manager LP and Penserra Capital Management LLC. View Insider Buying and Selling for PetMed Express.

How do I buy PetMed Express stock?

Shares of PetMed Express can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PetMed Express' stock price today?

One share of PetMed Express stock can currently be purchased for approximately $45.09.

How big of a company is PetMed Express?

PetMed Express has a market capitalization of $929.03 million and generates $249.18 million in revenue each year. The company earns $23.81 million in net income (profit) each year or $1.49 on an earnings per share basis. PetMed Express employs 187 workers across the globe.

How can I contact PetMed Express?

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for PetMed Express (PETS)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  155 (Vote Underperform)
Total Votes:  220
MarketBeat's community ratings are surveys of what our community members think about PetMed Express and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

PetMed Express (NASDAQ:PETS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.202.202.202.00
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $40.00$40.00$38.50$13.00
Price Target Upside: 14.55% upside14.55% upside6.29% upside38.71% downside

PetMed Express (NASDAQ:PETS) Consensus Price Target History

Price Target History for PetMed Express (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/27/2017Noble FinancialReiterated RatingHoldN/AView Rating Details
10/2/2017Credit Suisse GroupReiterated RatingUnderperform$19.00LowView Rating Details
8/24/2017SidotiUpgradeNeutral -> Buy$47.00HighView Rating Details
8/21/2017Craig HallumReiterated RatingHold$43.00 -> $40.00HighView Rating Details
7/24/2017Northcoast ResearchUpgradeNeutral -> Buy$54.00HighView Rating Details
(Data available from 12/18/2015 forward)

Earnings

PetMed Express (NASDAQ:PETS) Earnings History and Estimates Chart

Earnings by Quarter for PetMed Express (NASDAQ:PETS)

PetMed Express (NASDAQ PETS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/22/2018$0.31N/AView Earnings Details
10/23/2017Q2 2018$0.30$0.43$63.41 million$66.70 millionViewN/AView Earnings Details
7/24/2017Q1 2018$0.38$0.45$77.32 million$79.66 millionViewN/AView Earnings Details
5/8/2017Q4 17$0.26$0.37$56.53 million$63.03 millionViewListenView Earnings Details
1/23/2017Q3 2017$0.25$0.24$52.70 million$52.90 millionViewN/AView Earnings Details
10/24/2016Q2$0.26$0.24$58.47 million$60.80 millionViewN/AView Earnings Details
7/25/2016Q1$0.31$0.32$72.90 million$72.49 millionViewN/AView Earnings Details
5/9/2016Q4$0.25$0.27$50.20 million$55.40 millionViewN/AView Earnings Details
1/25/2016Q316$0.25$0.24$49.28 million$50.90 millionViewListenView Earnings Details
10/19/2015Q216$0.20$0.22$58.34 million$56.70 millionViewListenView Earnings Details
7/20/2015Q116$0.28$0.29$73.04 million$71.60 millionViewN/AView Earnings Details
5/4/2015Q415$0.25$0.25$49.11 million$50.00 millionViewN/AView Earnings Details
1/20/2015Q315$0.24$0.24$49.26 million$49.30 millionViewN/AView Earnings Details
10/20/2014Q215$0.21$0.19$61.22 million$57.60 millionViewListenView Earnings Details
7/21/2014Q115$0.25$0.25$74.25 million$72.50 millionViewN/AView Earnings Details
5/5/2014Q414$0.22$0.23$55.02 million$48.60 millionViewN/AView Earnings Details
1/21/2014Q214$0.23$0.23$52.06 million$50.10 millionViewN/AView Earnings Details
10/21/2013Q213$0.22$0.20$60.33 million$80.50 millionViewN/AView Earnings Details
7/22/2013Q1 2013$0.22$0.24$69.55 million$74.20 millionViewN/AView Earnings Details
5/6/2013Q4 2012$0.21$0.23$55.31 million$51.10 millionViewN/AView Earnings Details
1/22/2013Q3 2012$0.17$0.23$49.97 million$49.60 millionViewN/AView Earnings Details
10/22/2012$0.17$0.20ViewN/AView Earnings Details
7/23/2012$0.23$0.20ViewN/AView Earnings Details
5/7/2012$0.18$0.20ViewN/AView Earnings Details
1/23/2012$0.16$0.19ViewN/AView Earnings Details
10/24/2011$0.15$0.19ViewN/AView Earnings Details
7/18/2011$0.24$0.22ViewN/AView Earnings Details
5/9/2011$0.23$0.19ViewN/AView Earnings Details
1/24/2011$0.20$0.20ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

PetMed Express (NASDAQ:PETS) Earnings Estimates

2017 EPS Consensus Estimate: $1.06
2018 EPS Consensus Estimate: $1.44
2019 EPS Consensus Estimate: $1.80
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.30$0.30$0.30
Q2 20172$0.23$0.28$0.26
Q3 20172$0.23$0.26$0.25
Q4 20172$0.25$0.26$0.26
Q1 20182$0.40$0.40$0.40
Q2 20182$0.28$0.28$0.28
Q3 20182$0.33$0.33$0.33
Q4 20182$0.43$0.43$0.43
Q1 20192$0.51$0.53$0.52
Q2 20192$0.42$0.46$0.44
Q3 20192$0.35$0.38$0.37
Q4 20192$0.45$0.49$0.47
(Data provided by Zacks Investment Research)

Dividends

PetMed Express (NASDAQ:PETS) Dividend Information

Most Recent Dividend:11/17/2017
Annual Dividend:$0.80
Dividend Yield:1.77%
Payout Ratio:53.69% (Trailing 12 Months of Earnings)
47.62% (Based on This Year's Estimates)
44.44% (Based on Next Year's Estimates)
Dividend Payments by Quarter for PetMed Express (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/24/2017quarterly$0.202.08%11/3/201711/6/201711/17/2017
7/24/2017quarterly$0.201.66%8/3/20178/7/20178/18/2017
5/8/2017quarterly$0.205/17/20175/19/20175/26/2017
1/23/2017quarterly$0.193.61%2/2/20172/6/20172/17/2017
10/24/2016quarterly$0.193.84%11/3/201611/7/201611/18/2016
7/25/2016quarterly$0.193.71%8/4/20168/8/20168/19/2016
5/9/2016quarterly$0.193.9%5/18/20165/20/20165/27/2016
1/25/2016quarterly$0.184.04%2/4/20162/8/20162/19/2016
10/19/2015quarterly$0.184.28%10/29/201511/2/201511/13/2015
7/20/2015quarterly$0.184.23%7/30/20158/3/20158/14/2015
5/4/2015quarterly$0.184.41%5/13/20155/15/20155/22/2015
1/20/2015quarterly$0.174.2%1/30/20152/3/20152/13/2015
10/20/2014quarterly$0.1710/30/201411/3/201411/14/2014
7/21/2014quarterly$0.174.79%7/31/20148/4/20148/15/2014
5/5/2014quarterly$0.175.22%5/14/20145/16/20145/23/2014
1/30/2014quarterly$0.175.14%2/10/20142/12/20142/21/2014
10/28/2013quarterly$0.174.56%11/6/201311/8/201311/22/2013
7/26/2013quarterly$0.174.16%8/8/20138/12/20138/23/2013
5/3/2013quarterly$0.154.65%5/13/20135/15/20135/24/2013
1/28/2013quarterly$0.154.64%2/6/20132/8/20132/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

PetMed Express (NASDAQ PETS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.00%
Institutional Ownership Percentage: 99.89%
Insider Trades by Quarter for PetMed Express (NASDAQ:PETS)
Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

PetMed Express (NASDAQ PETS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/27/2017Ronald J KornDirectorSell1,000$35.57$35,570.00View SEC Filing  
8/1/2017Robert C SchweitzerDirectorSell2,500$49.18$122,950.00View SEC Filing  
7/28/2017Ronald J KornDirectorSell5,000$48.18$240,900.00View SEC Filing  
7/27/2017Bruce S RosenbloomCFOSell6,833$50.18$342,879.94View SEC Filing  
7/27/2017Robert C SchweitzerDirectorSell5,000$48.60$243,000.00View SEC Filing  
5/16/2017Frank J FormicaDirectorSell5,000$35.32$176,600.00View SEC Filing  
5/10/2017Gian FulgoniDirectorSell35,000$32.22$1,127,700.00View SEC Filing  
5/8/2017Bruce S RosenbloomInsiderSell9,000$27.00$243,000.00View SEC Filing  
5/1/2017Bruce S RosenbloomInsiderSell1,500$24.00$36,000.00View SEC Filing  
12/13/2016Menderes AkdagCEOSell10,000$23.00$230,000.00View SEC Filing  
12/9/2016Bruce S RosenbloomInsiderSell1,500$23.00$34,500.00View SEC Filing  
12/7/2016Menderes AkdagCEOSell3,107$22.75$70,684.25View SEC Filing  
11/25/2016Menderes AkdagCEOSell6,274$22.25$139,596.50View SEC Filing  
11/16/2016Frank J FormicaDirectorSell10,000$21.75$217,500.00View SEC Filing  
11/14/2016Bruce S RosenbloomInsiderSell3,000$21.75$65,250.00View SEC Filing  
11/14/2016Menderes AkdagCEOSell40,000$21.63$865,200.00View SEC Filing  
10/10/2016Bruce S RosenbloomInsiderSell1,500$21.00$31,500.00View SEC Filing  
10/10/2016Menderes AkdagCEOSell10,000$21.00$210,000.00View SEC Filing  
9/22/2016Menderes AkdagCEOSell10,000$20.75$207,500.00View SEC Filing  
8/12/2016Bruce S RosenbloomInsiderSell8,000$20.38$163,040.00View SEC Filing  
8/11/2016Robert C SchweitzerDirectorSell3,000$20.59$61,770.00View SEC Filing  
8/9/2016Robert C SchweitzerDirectorSell4,500$20.52$92,340.00View SEC Filing  
8/1/2016Ronald J KornDirectorSell4,000$20.76$83,040.00View SEC Filing  
5/9/2016Bruce S RosenbloomCFOSell5,500$19.54$107,470.00View SEC Filing  
3/30/2016Bruce S RosenbloomCFOSell1,500$18.00$27,000.00View SEC Filing  
3/14/2016Bruce S RosenbloomCFOSell3,000$17.25$51,750.00View SEC Filing  
2/22/2016Ronald J KornDirectorSell5,000$16.76$83,800.00View SEC Filing  
1/22/2016Bruce S RosenbloomCFOSell750$18.50$13,875.00View SEC Filing  
11/20/2015Ronald J KornDirectorSell1,000$17.01$17,010.00View SEC Filing  
7/14/2015Bruce S RosenbloomCFOSell400$18.25$7,300.00View SEC Filing  
7/13/2015Bruce S RosenbloomCFOSell100$18.25$1,825.00View SEC Filing  
6/19/2015Bruce S RosenbloomCFOSell1,000$17.88$17,880.00View SEC Filing  
6/19/2015Menderes AkdagCEOSell8,000$17.75$142,000.00View SEC Filing  
6/4/2015Menderes AkdagCEOSell9,930$17.50$173,775.00View SEC Filing  
5/8/2015Frank J FormicaDirectorSell7,500$16.51$123,825.00View SEC Filing  
4/23/2015Menderes AkdagCEOSell10,000$17.25$172,500.00View SEC Filing  
4/20/2015Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
4/13/2015Menderes AkdagCEOSell7,499$16.75$125,608.25View SEC Filing  
4/13/2015Ronald J KornDirectorSell2,000$16.75$33,500.00View SEC Filing  
4/8/2015Menderes AkdagCEOSell2,501$16.75$41,891.75View SEC Filing  
3/30/2015Menderes AkdagCEOSell10,000$16.50$165,000.00View SEC Filing  
3/25/2015Ronald J KornDirectorSell2,000$16.25$32,500.00View SEC Filing  
1/21/2015Menderes AkdagCEOSell60,000$15.63$937,800.00View SEC Filing  
1/20/2015Bruce S RosenbloomCFOSell2,167$15.40$33,371.80View SEC Filing  
8/15/2014Ronald J KornDirectorSell2,000$14.13$28,260.00View SEC Filing  
7/22/2014Bruce S RosenbloomCFOSell1,000$14.13$14,130.00View SEC Filing  
7/21/2014Bruce S RosenbloomCFOSell500$14.00$7,000.00View SEC Filing  
6/12/2014Bruce S RosenbloomCFOSell1,500$13.50$20,250.00View SEC Filing  
9/13/2013Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
9/11/2013Bruce S RosenbloomCFOSell6,666$16.21$108,055.86View SEC Filing  
8/14/2013Ronald KornDirectorSell1,000$16.25$16,250.00View SEC Filing  
8/12/2013Ronald KornDirectorSell1,000$16.18$16,180.00View SEC Filing  
7/31/2013Frank J FormicaDirectorSell7,000$16.39$114,730.00View SEC Filing  
7/22/2013Bruce S RosenbloomCFOSell6,250$16.74$104,625.00View SEC Filing  
3/6/2013Ronald J KornDirectorSell2,000$13.50$27,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

PetMed Express (NASDAQ PETS) News Headlines

Source:
DateHeadline
At $45.09, Is It Time To Buy PetMed Express Inc (NASDAQ:PETS)?At $45.09, Is It Time To Buy PetMed Express Inc (NASDAQ:PETS)?
finance.yahoo.com - December 18 at 10:34 AM
Walgreens Closes PharMerica Buyout as KKR's Minority PartnerWalgreens Closes PharMerica Buyout as KKR's Minority Partner
finance.yahoo.com - December 18 at 10:34 AM
Teleflex (TFX), HealthTrust Rebond on Respiratory ProductsTeleflex (TFX), HealthTrust Rebond on Respiratory Products
finance.yahoo.com - December 18 at 10:34 AM
CVS Health Banks on Solid Pharmacy Services, Competition RifeCVS Health Banks on Solid Pharmacy Services, Competition Rife
www.zacks.com - December 14 at 10:19 AM
Northcoast Research Weighs in on PetMed Express, Inc.s Q3 2018 Earnings (PETS)Northcoast Research Weighs in on PetMed Express, Inc.'s Q3 2018 Earnings (PETS)
www.americanbankingnews.com - December 13 at 2:16 PM
Smith & Nephew's Rotation Medical Deal Aids Tissue Regen ArmSmith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm
finance.yahoo.com - December 12 at 10:38 AM
Cooper Companies (COO) Tops Q4 Earnings & Revenue Estimates - NasdaqCooper Companies (COO) Tops Q4 Earnings & Revenue Estimates - Nasdaq
www.nasdaq.com - December 11 at 10:55 AM
PetMed Express, Inc. (PETS) Expected to Post Earnings of $0.35 Per SharePetMed Express, Inc. (PETS) Expected to Post Earnings of $0.35 Per Share
www.americanbankingnews.com - December 9 at 11:28 AM
PetMed Express (PETS) Lifted to Strong-Buy at BidaskClubPetMed Express (PETS) Lifted to Strong-Buy at BidaskClub
www.americanbankingnews.com - December 9 at 7:02 AM
PetMed Express Target of Unusually Large Options Trading (PETS)PetMed Express Target of Unusually Large Options Trading (PETS)
www.americanbankingnews.com - December 8 at 1:32 AM
Just who is EagleBanks nemesis? Heres what we know.Just who is EagleBank's nemesis? Here's what we know.
www.bizjournals.com - December 6 at 4:45 PM
PetMed Express Joins Elite List Of Stocks With 95-Plus Composite RatingPetMed Express Joins Elite List Of Stocks With 95-Plus Composite Rating
finance.yahoo.com - December 6 at 4:45 PM
IDEXX Laboratories Banks on Global Prospects, CAG StrengthIDEXX Laboratories Banks on Global Prospects, CAG Strength
www.zacks.com - December 6 at 10:27 AM
Heres Why You Should Invest in PetMed (PETS) Stock NowHere's Why You Should Invest in PetMed (PETS) Stock Now
finance.yahoo.com - December 6 at 10:27 AM
Amazon (AMZN) Rules E-Commerce: 3 Contenders to Watch OutAmazon (AMZN) Rules E-Commerce: 3 Contenders to Watch Out
finance.yahoo.com - December 6 at 10:27 AM
Boston Scientific (BSX) Shares Drop on LOTUS Relaunch Delay - NasdaqBoston Scientific (BSX) Shares Drop on LOTUS Relaunch Delay - Nasdaq
www.nasdaq.com - December 2 at 9:08 AM
Bio-Rad (BIO) at a 52-Week High: Whats Driving the Stock? - Yahoo FinanceBio-Rad (BIO) at a 52-Week High: What's Driving the Stock? - Yahoo Finance
finance.yahoo.com - December 2 at 9:08 AM
PetMed Express, Inc. (PETS) Receives Consensus Rating of "Hold" from AnalystsPetMed Express, Inc. (PETS) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - December 2 at 1:50 AM
Boston Scientific (BSX) Shares Drop on LOTUS Relaunch DelayBoston Scientific (BSX) Shares Drop on LOTUS Relaunch Delay
www.zacks.com - December 1 at 5:29 PM
Heres Why You Should Invest in Baxter (BAX) Stock Right NowHere's Why You Should Invest in Baxter (BAX) Stock Right Now
www.zacks.com - November 30 at 10:47 AM
Amazon (AMZN) Witnesses Biggest Cyber Monday Bonanza EverAmazon (AMZN) Witnesses Biggest Cyber Monday Bonanza Ever
finance.yahoo.com - November 30 at 10:47 AM
Varian's Partners Penn Medicine, Proton Therapy in FocusVarian's Partners Penn Medicine, Proton Therapy in Focus
finance.yahoo.com - November 30 at 10:47 AM
Hologic's FDA Nod for Quantra Software Boosts Breast HealthHologic's FDA Nod for Quantra Software Boosts Breast Health
finance.yahoo.com - November 27 at 4:36 PM
Heres Why You Should Invest in Masimo (MASI) Right NowHere's Why You Should Invest in Masimo (MASI) Right Now
www.zacks.com - November 26 at 5:39 PM
Luminex (LMNX) at 52-Week High: Whats Driving the Stock? - Yahoo FinanceLuminex (LMNX) at 52-Week High: What's Driving the Stock? - Yahoo Finance
finance.yahoo.com - November 26 at 9:11 AM
Luminex (LMNX) at 52-Week High: Whats Driving the Stock? - NasdaqLuminex (LMNX) at 52-Week High: What's Driving the Stock? - Nasdaq
www.nasdaq.com - November 24 at 5:42 PM
PetMed (PETS) Down 7.8% Since Earnings Report: Can It Rebound?PetMed (PETS) Down 7.8% Since Earnings Report: Can It Rebound?
finance.yahoo.com - November 24 at 9:09 AM
Heres Why You Should Invest in Align Technology (ALGN) Now - NasdaqHere's Why You Should Invest in Align Technology (ALGN) Now - Nasdaq
www.nasdaq.com - November 23 at 5:39 PM
PetMed (PETS) Down 7.8% Since Earnings Report: Can It Rebound? - NasdaqPetMed (PETS) Down 7.8% Since Earnings Report: Can It Rebound? - Nasdaq
www.nasdaq.com - November 23 at 5:39 PM
Zacks: Brokerages Anticipate PetMed Express, Inc. (PETS) Will Announce Quarterly Sales of $57.42 MillionZacks: Brokerages Anticipate PetMed Express, Inc. (PETS) Will Announce Quarterly Sales of $57.42 Million
www.americanbankingnews.com - November 23 at 7:30 AM
$0.35 EPS Expected for PetMed Express, Inc. (PETS) This Quarter$0.35 EPS Expected for PetMed Express, Inc. (PETS) This Quarter
www.americanbankingnews.com - November 21 at 1:26 PM
DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay - NasdaqDENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay - Nasdaq
www.nasdaq.com - November 21 at 9:17 AM
Was PetMed Express Inc’s (PETS) Earnings Growth Better Than Industry?Was PetMed Express Inc’s (PETS) Earnings Growth Better Than Industry?
finance.yahoo.com - November 18 at 10:53 AM
Q3 2018 EPS Estimates for PetMed Express, Inc. (PETS) Boosted by Northcoast ResearchQ3 2018 EPS Estimates for PetMed Express, Inc. (PETS) Boosted by Northcoast Research
www.americanbankingnews.com - November 18 at 12:20 AM
Hill-Rom (HRC) Banks on Product Launches, Competition Rife - NasdaqHill-Rom (HRC) Banks on Product Launches, Competition Rife - Nasdaq
www.nasdaq.com - November 9 at 11:17 AM
PetMed Express, Inc. breached its 50 day moving average in a Bearish Manner : PETS-US : November 8, 2017PetMed Express, Inc. breached its 50 day moving average in a Bearish Manner : PETS-US : November 8, 2017
finance.yahoo.com - November 9 at 11:16 AM
SurModics (SRDX) Posts Earnings in Q4, Revenues Top EstimatesSurModics (SRDX) Posts Earnings in Q4, Revenues Top Estimates
finance.yahoo.com - November 9 at 11:16 AM
Globus Medical (GMED) Q3 Earnings In Line, View ReiteratedGlobus Medical (GMED) Q3 Earnings In Line, View Reiterated
finance.yahoo.com - November 9 at 11:16 AM
Amedisys (AMED) Q3 Earnings Beat, Revenues Miss EstimatesAmedisys (AMED) Q3 Earnings Beat, Revenues Miss Estimates
finance.yahoo.com - November 9 at 11:16 AM
Hill-Rom (HRC) Banks on Product Launches, Competition RifeHill-Rom (HRC) Banks on Product Launches, Competition Rife
finance.yahoo.com - November 9 at 11:16 AM
Genomic Health (GHDX) Swings to Earnings in Q3, Revenues LagGenomic Health (GHDX) Swings to Earnings in Q3, Revenues Lag
finance.yahoo.com - November 9 at 11:16 AM
Hologic (HOLX) Q4 Earnings & Revenues Top, Margins DownHologic (HOLX) Q4 Earnings & Revenues Top, Margins Down
finance.yahoo.com - November 9 at 11:16 AM
A Long: PetMed, And A Short: Snap - PetMed Express, Inc ... - Seeking AlphaA Long: PetMed, And A Short: Snap - PetMed Express, Inc ... - Seeking Alpha
seekingalpha.com - November 7 at 8:37 AM
PetMed Express, Inc. (PETS) Receives Average Rating of "Hold" from AnalystsPetMed Express, Inc. (PETS) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - November 7 at 1:52 AM
PetMed Express, Inc. (PETS) Expected to Announce Earnings of $0.35 Per SharePetMed Express, Inc. (PETS) Expected to Announce Earnings of $0.35 Per Share
www.americanbankingnews.com - November 1 at 3:10 AM
Insider Selling: PetMed Express, Inc. (PETS) Director Sells 1,000 Shares of StockInsider Selling: PetMed Express, Inc. (PETS) Director Sells 1,000 Shares of Stock
www.americanbankingnews.com - October 31 at 11:26 AM
Corporate News Blog - Alkermes Clinical Data on ALKS 8700 for MS, Demonstrates Safety and Gastrointestinal TolerabilityCorporate News Blog - Alkermes' Clinical Data on ALKS 8700 for MS, Demonstrates Safety and Gastrointestinal Tolerability
finance.yahoo.com - October 31 at 7:48 AM
Petmed Express Inc (PETS) Earns Hold Rating from Noble FinancialPetmed Express Inc (PETS) Earns Hold Rating from Noble Financial
www.americanbankingnews.com - October 28 at 11:10 AM
PetMed Express: Still Concerns Behind The Noise - Seeking AlphaPetMed Express: Still Concerns Behind The Noise - Seeking Alpha
seekingalpha.com - October 27 at 9:42 AM
Zacks.com featured highlights: Deckers Outdoor, PetMed Express, WABCO Holdings, United Rentals and CIT GroupZacks.com featured highlights: Deckers Outdoor, PetMed Express, WABCO Holdings, United Rentals and CIT Group
finance.yahoo.com - October 27 at 9:42 AM

SEC Filings

PetMed Express (NASDAQ:PETS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

PetMed Express (NASDAQ:PETS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

PetMed Express (NASDAQ PETS) Stock Chart for Monday, December, 18, 2017

Loading chart…

This page was last updated on 12/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.